v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 48,929,895 $ 53,317,405
Restricted cash 121,214 131,567
Short-term investments 15,692,548 12,149,003
Trade receivables 45,368
Inventories 1,720 3,008
Prepaid research and development expenses 28,451 51,993
Other prepaid expenses and current assets 585,141 770,485
Total current assets 65,358,969 66,468,829
Property and equipment, net 1,448,305 1,474,937
Restricted cash, long-term 102,308 102,305
Operating lease right-of-use assets 838,121 899,505
TOTAL ASSETS 67,747,703 68,945,576
Current liabilities    
Accounts payable 2,496,074 2,209,552
Accrued expenses 2,648,626 3,014,156
Current portion of operating lease liabilities 127,408 121,368
Total current liabilities 5,272,108 5,345,076
Operating lease liabilities, net of current portion 736,855 802,433
TOTAL LIABILITIES 6,008,963 6,147,509
COMMITMENTS AND CONTINGENCIES (Note 4)
STOCKHOLDERS’ EQUITY    
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 181,622 shares issued and outstanding at June 30, 2022 and December 31, 2021 182 182
Common stock - $0.001 par value: 160,000,000 shares authorized; 41,106,777 and 38,086,437 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 41,107 38,086
Accumulated other comprehensive gain 39,519 87,130
Additional paid-in capital 321,956,046 308,331,750
Accumulated deficit (260,298,114) (245,659,081)
TOTAL STOCKHOLDERS’ EQUITY 61,738,740 62,798,067
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 67,747,703 $ 68,945,576